LD-2 disclosure · 3rd Quarter - Report
ARDELYX
Income$60Kfee reported
Client
- Name
- ARDELYX
- Description
- BioPharma Company
- Location
- Massachusetts · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedicare/Medicaid
Issues related to the 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-105-F), specifically the inclusion of oral-only drugs in the ESRD PPS Bundled Payment.
LobbyistsJOHN MCMANUS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB)